Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Asthma
Interventions
DRUG

L-arginine

subjects will take matching 0.01 g/kg/day of L-arginine in divided doses for thre months.

DRUG

Placebo

Placebo tablets that match the L-arginine intervention tablets will be given for three months

Trial Locations (1)

95817

University of California, Davis General Clinical Research Center, Sacramento

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

University of California, Davis

OTHER

NCT00280683 - Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma | Biotech Hunter | Biotech Hunter